Viewing StudyNCT04524000



Ignite Creation Date: 2024-05-06 @ 3:06 PM
Last Modification Date: 2024-10-26 @ 1:43 PM
Study NCT ID: NCT04524000
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2020-08-19

Brief Title: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords:
Name View
Japanese population View
HR View
HER2-negative View
PIK3CA mutation View
Advanced breast cancer View
Alpelisib View
Fulvestrant View
open-label View
Part 1 View
Part 2 View